DRLAX
Price
$8.26
Change
+$0.12 (+1.47%)
Updated
Apr 17 closing price
Net Assets
284.82M
MGLIX
Price
$15.61
Change
+$0.23 (+1.50%)
Updated
Apr 17 closing price
Net Assets
2.16B
Ad is loading...

DRLAX vs MGLIX

Header iconDRLAX vs MGLIX Comparison
Open Charts DRLAX vs MGLIXBanner chart's image
BNY Mellon Developed Markets RE Scs - A
Price$8.26
Change+$0.12 (+1.47%)
VolumeN/A
Net Assets284.82M
MFS Global Real Estate I
Price$15.61
Change+$0.23 (+1.50%)
VolumeN/A
Net Assets2.16B
DRLAX vs MGLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DRLAX vs. MGLIX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRLAX is a StrongBuy and MGLIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.16B vs. DRLAX (285M). MGLIX pays higher dividends than DRLAX: MGLIX (2.61) vs DRLAX (2.42). DRLAX was incepted earlier than MGLIX: DRLAX (18 years) vs MGLIX (16 years). DRLAX (1.77) is less costly to investors than MGLIX (0.95). MGLIX (48.00) and DRLAX (47.81) have comparable annual turnover. MGLIX has a lower initial minimum investment than DRLAX: MGLIX (0) vs DRLAX (1000). DRLAX annual gain was more profitable for investors over the last year : 12.07 vs. MGLIX (0.96). DRLAX return over 5 years is better than : 20.98 vs. MGLIX (16.14).
DRLAXMGLIXDRLAX / MGLIX
Total Expense Ratio1.300.94138%
Annual Report Gross Expense Ratio1.770.95186%
Fund Existence18 years16 years-
Gain YTD-1.094-4.30225%
Front Load6%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets285M2.16B13%
Annual Yield % from dividends2.422.6193%
Returns for 1 year12.070.961,251%
Returns for 3 years-15.59-22.7768%
Returns for 5 years20.9816.14130%
Returns for 10 years3.1618.1517%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DTCAX16.09N/A
N/A
BNY Mellon Sust US Equity A
GSCGX28.83N/A
N/A
Goldman Sachs Large Cap Core A
PXGOX15.46N/A
N/A
Impax Global Opportunities Institutional
EEMDX7.67N/A
N/A
MFS Emerging Markets Equity Research R1
JACNX23.82-0.10
-0.42%
Janus Henderson Contrarian D